Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Assets AverageEnterprise ValueEquity AverageEquity RatioInventory AverageInvested CapitalMarket Capitalization

RedHill Biopharma (RDHL) Return on Sales: 2009-2024

Historic Return on Sales for RedHill Biopharma (RDHL) over the last 14 years, with Dec 2024 value amounting to -1.03%.

  • RedHill Biopharma's Return on Sales rose 106.00% to -1.12% in Q2 2023 from the same period last year, while for Jun 2023 it was -1.12%, marking a year-over-year increase of 106.00%. This contributed to the annual value of -1.03% for FY2024, which is 469.00% down from last year.
  • As of FY2024, RedHill Biopharma's Return on Sales stood at -1.03%, which was down 128.07% from 3.66% recorded in FY2023.
  • In the past 5 years, RedHill Biopharma's Return on Sales ranged from a high of 3.66% in FY2023 and a low of -1.16% during FY2022.
  • Moreover, its 3-year median value for Return on Sales was -1.03% (2024), whereas its average is 0.49%.
  • In the last 5 years, RedHill Biopharma's Return on Sales crashed by 621bps in 2020 and then surged by 482bps in 2023.
  • Yearly analysis of 5 years shows RedHill Biopharma's Return on Sales stood at 0.80% in 2020, then plummeted by 194bps to -1.14% in 2021, then fell by 2bps to -1.16% in 2022, then surged by 482bps to 3.66% in 2023, then tumbled by 469bps to -1.03% in 2024.